[
    {
        "outcome_uid": "19a3389b",
        "clinical_question": "Should patients with RA on DMARDs who are in low disease activity gradually taper off DMARDs, abruptly withdraw DMARDs, or continue DMARDS at the same doses?",
        "population": "Patients with rheumatoid arthritis (RA) who are on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) and in low disease activity",
        "intervention": "Gradually taper off DMARDs",
        "comparator": "Abruptly withdraw DMARDs or continue DMARDs at the same doses",
        "outcome": "Flare (follow up: range 6 months to 12 months)",
        "importance": "CRITICAL",
        "related_paper_list": [
            "566c1573"
        ],
        "assessment_results": {
            "GRADE": {
                "Study design": "RANDOMIZED_CONTROLLED_TRIAL"
            }
        }
    }
]